Eye Complex
Eye Complex, licence 80078887: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- CellChem Pharmaceuticals Inc.
- NPN or DIN-HM
- 80078887
- Status
- Active licence
- Licence date
- 5 July 2017
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Tagetes erecta - Fleur | 6.0 milligramme | Not calculated |
| (3R,3'R)-bêta,bêta-Carotène-3,3'-diol Source : Tagetes erecta - Fleur | 1.0 milligramme | Not calculated |
Non-medicinal ingredients
Cire d'abeille jaune, Huile de soja, Gélatine, Oxyde de fer noir, Sorbitol, Parahydroxybenzoate de méthyle, Oxyde de Fer Jaune, (p)-hydroxybenzoate de propyle, Glycérine, Oxyde de fer (Fe2O3), Lécithine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1.0 Capsule ; maximum: 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to improve macular pigment optical density. Helps to reduce the risk of developing cataracts. Helps to support eye health in conditions, such as cataracts and age related macular degeneration.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80078887
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.